Ineffective risk-reward learning in schizophrenia.


Journal

Psychiatry research
ISSN: 1872-7123
Titre abrégé: Psychiatry Res
Pays: Ireland
ID NLM: 7911385

Informations de publication

Date de publication:
11 2020
Historique:
received: 26 04 2020
revised: 02 08 2020
accepted: 04 08 2020
pubmed: 18 8 2020
medline: 23 2 2021
entrez: 18 8 2020
Statut: ppublish

Résumé

The underpinnings of poor decision-making in schizophrenia could reflect excessively risky or inhibited behaviors. This study employed the Balloon Analogue Risk Task (BART) to compare decision-making in schizophrenia cases to that of healthy controls. Individuals with schizophrenia performed significantly differently across three trials, failing to improve their performance as shown by the control group. In the control group, cognitive ability, measured with the Wechsler Adult Intelligence Scale (WAIS-III) showed that Perceptual Organization scores predicted Average Inflations per Trial, Total Balloon Pops, and Total Earnings. Although the schizophrenia cases failed to learn, group performance on the BART was not associated with cognitive ability, but regression analyses showed 41.4% of average inflations per trial were explained by Excitement, Delusions, Emotional Withdrawal, and Poor Rapport; total balloon pops were only explained by emotional withdrawal and Total Earnings were reduced by Delusions, Excitement and Poor Rapport. Only healthy participants demonstrated a relation between cognitive ability performance improvement across trials. Schizophrenia cases showed less risk-taking, and earned significantly less money overall. Identifying the determinants of poor decision-making could inform interventions and possible treatments to improve their function and perhaps be of relevance to public safety if decisions are overly risky.

Identifiants

pubmed: 32798934
pii: S0165-1781(20)31086-6
doi: 10.1016/j.psychres.2020.113370
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

113370

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Auteurs

Emeka Boka (E)

Department of Psychiatry, Neuroscience, Genetics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Jill Del Pozzo (JD)

Department of Psychology, Montclair State University, Montclair, NJ, USA.

Deborah Goetz (D)

Department of Psychiatry, Neuroscience, Genetics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Brooke Remsen (B)

Department of Psychiatry, Neuroscience, Genetics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Julie Walsh-Messinger (J)

Department of Psychology, University of Dayton, Dayton, OH, USA; Department of Psychiatry, Wright State University Boonshoft School of Medicine, Dayton, OH, USA.

Mara Getz (M)

Department of Psychiatry, Neuroscience, Genetics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Daniel Antonius (D)

Department of Psychiatry, Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, Buffalo, NY, USA. Electronic address: danantonius@gmail.com.

Dolores Malaspina (D)

Department of Psychiatry, Neuroscience, Genetics, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: dolores.malaspina@mssm.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH